Aug 11 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES SECOND QUARTER 2020 FINANCIAL RESULTS AND BUSINESS UPDATE
* Q2 LOSS PER SHARE $18.91
* Q2 EARNINGS PER SHARE ESTIMATE $-0.50 -- REFINITIV IBES DATA
* EXPECTS ITS CASH AS OF JUNE 30, 2020 WILL ENABLE CO TO FUND ITS OPERATIONS INTO 2024